NEIGHBORHOOD Consortium for POAG Genetics
NEIGHBORHOOD Consortium for POAG Genetics
批准号:
10331322
负责人:
Janey L Wiggs
金额:
$78.98万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
未结题
起止时间:
2012-08-01 至 2026-01-31
关键词:
AffectAgeBiologicalBiological ProcessBlindnessCandidate Disease GeneCaucasiansCellular AssayClinVarClinical DataCodeCommunicationComplexDataData AnalysesDatabasesDevelopmentDiagnosisDiseaseDrug TargetingEnsureEtiologyEuropeanEventFunctional disorderFundingGene FrequencyGenesGeneticGenetic studyGenomicsGlaucomaGoalsHeritabilityIndividualJointsLogistic RegressionsMeasurementMethodsMolecularNeighborhoodsNerve DegenerationNormal RangeOnline SystemsOptic NervePathogenesisPathogenicityPathway interactionsPersonsPhysiologic Intraocular PressurePopulationPredispositionPrevention strategyPrevention therapyPrimary Open Angle GlaucomaPrimary PreventionProcessProteinsPublic HealthQuality ControlRegulationResearchResearch PersonnelResourcesRetinal Ganglion CellsRisk FactorsSamplingSingle Nucleotide PolymorphismSubgroupTestingTherapeuticTissuesVariantVisual FieldsZebrafishage relatedbasebiobankcase controlcohortcurative treatmentsdbSNPexomeexome sequencinggenetic architecturegenetic variantgenome wide association studygenomic datainsertion/deletion mutationinsightinterestmodifiable riskmouse modelnew therapeutic targetnovelnovel therapeuticsoptic nerve disorderrare variantrisk variantscreeningsingle cell sequencingtherapeutic targettraittranscriptome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Primary open-angle glaucoma (POAG) is an intraocular pressure (IOP) related, progressive optic neuropathy
that ultimately leads to blindness. Permanent visual field loss from POAG is a condition of public health
significance worldwide. The etiology of POAG is poorly understood and primary prevention is not possible.
Elevated intraocular pressure (IOP) is a modifiable risk factor, however, many individuals have IOP elevation
without optic nerve disease , and at least 33% of POAG cases have progressive retinal ganglion cell loss
despite IOP measurements in the normal range, a condition defined as normal-tension glaucoma (NTG).
Preventative or neuro-protective therapies for glaucoma are not yet available and little is known about the
molecular events that influence susceptibility to glaucomatous optic nerve degeneration. The overall goal of
our research is to elucidate the pathogenesis of POAG allowing for implementation of effective screening and
prevention strategies and development of novel therapies. POAG has significant heritability and recent
genome-wide association studies, including our NEIGHBORHOOD GWAS, have identified 30 POAG loci
defined by common genomic variants. However, in addition to common variants the complex POAG genetic
architecture is likely to also include contributions from rare coding variants that implicate specific genes in
disease pathogenicity, as has been discovered for other complex traits. Large-scale studies of rare coding
variation in glaucoma populations have not yet been done. The focus of this competing renewal is to
comprehensively examine the contributions of coding variation to POAG and the HTG and NTG subgroups
with a primary goal of identifying novel therapeutic targets and specifically those with neuro-protective
potential. For the next funding period we propose the following specific aims: 1) Obtain high quality whole
exome sequence (WES) data for POAG cases and controls using state-of-the-art sequencing and robust
variant calling and annotation pipelines; 2) Assess contribution of rare coding variants to POAG and to NTG
and HTG subgroups; and 3) Build a web-based platform for data analysis, data-sharing and communication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining early-onset glaucomagenetic etiologies
-
批准号:10249270
-
项目类别:
-
资助金额:$70.74万
-
财政年份:2020
-
负责人:Janey L Wiggs
-
依托单位:
Defining early-onset glaucomagenetic etiologies
-
批准号:10448282
-
项目类别:
-
资助金额:$70.74万
-
财政年份:2020
-
负责人:Janey L Wiggs
-
依托单位:
Defining early-onset glaucomagenetic etiologies
-
批准号:10662296
-
项目类别:
-
资助金额:$72.92万
-
财政年份:2020
-
负责人:Janey L Wiggs
-
依托单位:
Defining early-onset glaucomagenetic etiologies
-
批准号:10034199
-
项目类别:
-
资助金额:$72.92万
-
财政年份:2020
-
负责人:Janey L Wiggs
-
依托单位:
Genetic Risk Factors for Central Vision Loss in Glaucoma
-
批准号:8622199
-
项目类别:
-
资助金额:$20.09万
-
财政年份:2013
-
负责人:Janey L Wiggs
-
依托单位:
Genetic Risk Factors for Central Vision Loss in Glaucoma
-
批准号:8510304
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2013
-
负责人:Janey L Wiggs
-
依托单位:
NEIGHBORHOOD Consortium for POAG Genetics
-
批准号:9148181
-
项目类别:
-
资助金额:$68.81万
-
财政年份:2012
-
负责人:Janey L Wiggs
-
依托单位:
NEIGHBORHOOD Consortium for POAG Genetics
-
批准号:9173545
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2012
-
负责人:Janey L Wiggs
-
依托单位:
The NEIGHBORHOOD: POAG Heritable Overall Operational Database
-
批准号:8265099
-
项目类别:
-
资助金额:$45.09万
-
财政年份:2012
-
负责人:Janey L Wiggs
-
依托单位:
The NEIGHBORHOOD: POAG Heritable Overall Operational Database
-
批准号:8511668
-
项目类别:
-
资助金额:$38.11万
-
财政年份:2012
-
负责人:Janey L Wiggs
-
依托单位:
The NEIGHBORHOOD: POAG Heritable Overall Operational Database
-
批准号:8728250
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2012
-
负责人:Janey L Wiggs
-
依托单位:
NEIGHBORHOOD Consortium for POAG Genetics
-
批准号:10557855
-
项目类别:
-
资助金额:$79.72万
-
财政年份:2012
-
负责人:Janey L Wiggs
-
依托单位:
NEIGHBORHOOD Consortium for POAG Genetics
-
批准号:8965452
-
项目类别:
-
资助金额:$71.41万
-
财政年份:2012
-
负责人:Janey L Wiggs
-
依托单位:
Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma
-
批准号:8323486
-
项目类别:
-
资助金额:$72.21万
-
财政年份:2011
-
负责人:Janey L Wiggs
-
依托单位:
Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma
-
批准号:8726405
-
项目类别:
-
资助金额:$68.0万
-
财政年份:2011
-
负责人:Janey L Wiggs
-
依托单位:
Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma
-
批准号:8926992
-
项目类别:
-
资助金额:$66.65万
-
财政年份:2011
-
负责人:Janey L Wiggs
-
依托单位:
Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma
-
批准号:8185917
-
项目类别:
-
资助金额:$78.04万
-
财政年份:2011
-
负责人:Janey L Wiggs
-
依托单位:
Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma
-
批准号:8539628
-
项目类别:
-
资助金额:$68.09万
-
财政年份:2011
-
负责人:Janey L Wiggs
-
依托单位:
Genetic and Environmental Risk Factors for Exfoliation Syndrome and Glaucoma
-
批准号:10013224
-
项目类别:
-
资助金额:$39.85万
-
财政年份:2011
-
负责人:Janey L Wiggs
-
依托单位:
India US Genetic Study of Ocular Quantitative Traits
-
批准号:7384583
-
项目类别:
-
资助金额:$18.89万
-
财政年份:2009
-
负责人:Janey L Wiggs
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: